Correlation Between Inhibrx and Hoth Therapeutics
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Hoth Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Hoth Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Hoth Therapeutics, you can compare the effects of market volatilities on Inhibrx and Hoth Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Hoth Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Hoth Therapeutics.
Diversification Opportunities for Inhibrx and Hoth Therapeutics
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Inhibrx and Hoth is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Hoth Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hoth Therapeutics and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Hoth Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hoth Therapeutics has no effect on the direction of Inhibrx i.e., Inhibrx and Hoth Therapeutics go up and down completely randomly.
Pair Corralation between Inhibrx and Hoth Therapeutics
Given the investment horizon of 90 days Inhibrx is expected to generate 0.64 times more return on investment than Hoth Therapeutics. However, Inhibrx is 1.56 times less risky than Hoth Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Hoth Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 2,526 in Inhibrx on September 26, 2024 and sell it today you would lose (1,077) from holding Inhibrx or give up 42.64% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Inhibrx vs. Hoth Therapeutics
Performance |
Timeline |
Inhibrx |
Hoth Therapeutics |
Inhibrx and Hoth Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Inhibrx and Hoth Therapeutics
The main advantage of trading using opposite Inhibrx and Hoth Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Hoth Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hoth Therapeutics will offset losses from the drop in Hoth Therapeutics' long position.Inhibrx vs. Fate Therapeutics | Inhibrx vs. Caribou Biosciences | Inhibrx vs. Karyopharm Therapeutics | Inhibrx vs. Hookipa Pharma |
Hoth Therapeutics vs. Oric Pharmaceuticals | Hoth Therapeutics vs. Lyra Therapeutics | Hoth Therapeutics vs. Inhibrx | Hoth Therapeutics vs. ESSA Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |